Safety and efficacy of nivolumab in challenging subgroups with advanced melanoma who progressed on or after ipilimumab treatment: A single-arm, open-label, phase II study (CheckMate 172)

2019 ◽  
Vol 121 ◽  
pp. 144-153 ◽  
Author(s):  
Dirk Schadendorf ◽  
Paolo A. Ascierto ◽  
John Haanen ◽  
Enrique Espinosa ◽  
Lev Demidov ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Melanoma ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Phase

scholarly journals An Open‐Label Phase II Study Evaluating the Safety and Efficacy of Ramucirumab Combined With mFOLFOX‐6 as First‐Line Therapy for Metastatic Colorectal Cancer

2014 ◽  
Vol 19 (4) ◽  
pp. 350-351 ◽  
Author(s):  
Rocio Garcia‐Carbonero ◽  
Fernando Rivera ◽  
Joan Maurel ◽  
Jean‐Pierre M. Ayoub ◽  
Malcolm J. Moore ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
First Line ◽  
Open Label ◽  
Safety And Efficacy ◽  
First Line Therapy ◽  
Line Therapy ◽  
Open Label Phase

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa

2007 ◽  
Vol 158 (3) ◽  
pp. 567-572 ◽  
Author(s):  
E.J. Giamarellos-Bourboulis ◽  
E. Pelekanou ◽  
A. Antonopoulou ◽  
H. Petropoulou ◽  
F. Baziaka ◽  
...  
Keyword(s):  
Phase Ii ◽  
Hidradenitis Suppurativa ◽  
Phase Ii Study ◽  
Open Label ◽  
Safety And Efficacy ◽  
Open Label Phase

scholarly journals Efficacy and safety of nivolumab in combination with ipilimumab in Japanese patients with advanced melanoma: An open-label, single-arm, multicentre phase II study

2018 ◽  
Vol 105 ◽  
pp. 114-126 ◽  
Author(s):  
Kenjiro Namikawa ◽  
Yoshio Kiyohara ◽  
Tatsuya Takenouchi ◽  
Hisashi Uhara ◽  
Hiroshi Uchi ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Study ◽  
Japanese Patients ◽  
Advanced Melanoma ◽  
Efficacy And Safety ◽  
Open Label ◽  
Multicentre Phase
Sign in / Sign up

Export Citation Format

Share Document